This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Mark Fleharty: Innovator in DNA/RNA Sequencing Technology
Introduction
Mark Fleharty is an accomplished inventor based in Albuquerque, NM (US). He has made significant contributions to the field of biotechnology, particularly in the area of DNA and RNA sequencing. His innovative work has the potential to advance the capabilities of biosensors and semiconductor technology.
Latest Patents
Mark Fleharty holds a patent for a groundbreaking invention titled "DNA/RNA sequencing using a semiconducting nanopore." This patent describes novel apparatuses that include biosensors utilizing semiconductor materials in electrolyte solutions. The technology relies on a unique property where a charged body in the electrolyte solution produces a detectable change in the local conductivity of the semiconductor as it approaches or travels near the semiconductor. This innovation represents a significant step forward in the field of molecular biology.
Career Highlights
Throughout his career, Mark has focused on developing technologies that enhance the efficiency and accuracy of genetic sequencing. His work has garnered attention for its potential applications in various fields, including medical diagnostics and personalized medicine. With a total of 1 patent, he continues to push the boundaries of what is possible in biotechnology.
Collaborations
Mark has collaborated with notable professionals in his field, including Frank B Van Swol and Dimiter N Petsev. These partnerships have allowed him to expand his research and contribute to innovative projects that aim to improve biosensor technology.
Conclusion
Mark Fleharty is a pioneering inventor whose work in DNA/RNA sequencing using semiconducting nanopores is paving the way for future advancements in biotechnology. His contributions are vital to the ongoing evolution of genetic research and its applications in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile